{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:32:09Z","timestamp":1777858329463,"version":"3.51.4"},"reference-count":45,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["UBACYT # 20020170100017BA"],"award-info":[{"award-number":["UBACYT # 20020170100017BA"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-Start-Up 2018 #2902"],"award-info":[{"award-number":["PICT-Start-Up 2018 #2902"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP # 11220130100266CO"],"award-info":[{"award-number":["PIP # 11220130100266CO"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Between 25% and 50% of patients suffering from treatment-resistant schizophrenia fail to achieve a clinical response with clozapine. The rapid identification and treatment of this subgroup of patients represents a challenge for healthcare practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To evaluate the relationship between metabolic alterations and the clinical response to clozapine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A multicenter, observational, case\u2013control study was performed. Patients diagnosed with schizophrenia treated with clozapine were eligible (minimum dose 400\u2009mg\/d for at least 8\u2009weeks and\/or clozapine plasma levels \u2a7e\u2009350\u2009\u00b5g\/mL). According to the Positive and Negative Syndrome Scale (PANSS) total score, patients were classified as clozapine-responsive (CR) (&lt;80\u2009points) or clozapine non-responsive (CNR) (\u2a7e80\u2009points). Groups were compared based on demographic and treatment-related characteristics, together with body mass index (BMI), waist circumference, insulin, leptin, and C-reactive protein plasma levels. Plasma levels of clozapine and its main metabolite, nor-clozapine, were measured in all the participants. In addition, the potential relationship between PANSS scores and leptin or insulin plasma levels was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 46 patients were included: 25 CR and 21 CNR. BMI and waist circumference, fasting insulin and leptin plasma levels were lower in the CNR group, while C-reactive protein was not different. Moreover, significant negative correlations were observed between PANSS positive and general psychopathology subscores, on one hand, and insulin and leptin plasma levels, on the other hand, as well as between PANSS negative subscores and leptin plasma levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our results suggest that the lack of metabolic effect induced by clozapine is associated with the lack of clinical response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811231181565","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T06:23:01Z","timestamp":1687933381000},"page":"1023-1029","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Body mass index, waist circumference, insulin, and leptin plasma levels differentiate between clozapine-responsive and clozapine-resistant schizophrenia"],"prefix":"10.1177","volume":"37","author":[{"given":"Guillermo","family":"H\u00f6nig","sequence":"first","affiliation":[{"name":"Hospital Interdisciplinario Psicoasistencial Jos\u00e9 Tiburcio Borda, Ciudad de Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico M","family":"Daray","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Instituto de Farmacolog\u00eda, Universidad de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demi\u00e1n","family":"Rodante","sequence":"additional","affiliation":[{"name":"Hospital Neuropsiqui\u00e1trico Braulio A. Moyano, Ciudad de Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5079-7607","authenticated-orcid":false,"given":"Lucas","family":"Drucaroff","sequence":"additional","affiliation":[{"name":"Instituto de Neurociencias, FLENI-CONICET, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Laura","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Instituto de Farmacolog\u00eda, Universidad de Buenos Aires, Buenos Aires, Argentina"},{"name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariela","family":"Lenze","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Instituto de Farmacolog\u00eda, Universidad de Buenos Aires, Buenos Aires, Argentina"},{"name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Facundo","family":"Garc\u00eda Bournissen","sequence":"additional","affiliation":[{"name":"Division of Pediatric Clinical Pharmacology, Department of Pediatrics, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6501-2916","authenticated-orcid":false,"given":"Silvia","family":"Wikinski","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Instituto de Farmacolog\u00eda, Universidad de Buenos Aires, Buenos Aires, Argentina"},{"name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas (CONICET), Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"bibr1-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.05.032"},{"key":"bibr2-02698811231181565","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05785yel"},{"key":"bibr3-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.7.1276"},{"key":"bibr4-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2020.12.002"},{"key":"bibr5-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sby058"},{"key":"bibr6-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-021-00192-x"},{"key":"bibr7-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1177\/0706743717718167"},{"key":"bibr8-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.04.010"},{"key":"bibr9-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-018-0908-0"},{"key":"bibr10-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32154-2"},{"key":"bibr11-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.01.022"},{"key":"bibr12-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"bibr13-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"bibr14-02698811231181565","volume-title":"The American Psychiatric Association Practice Guideline for the Treatment of Patients with Schizophrenia","author":"Keepers GA","year":"2021","edition":"3"},{"key":"bibr15-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(03)00111-8"},{"key":"bibr16-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000649"},{"key":"bibr17-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000476"},{"key":"bibr18-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01308.x"},{"key":"bibr19-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbu001"},{"key":"bibr20-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2018.11.031"},{"key":"bibr21-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.1702"},{"key":"bibr22-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.4.600"},{"key":"bibr23-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000639"},{"key":"bibr24-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(01)00326-7"},{"key":"bibr25-02698811231181565","unstructured":"National Institute for Health and Care Excellence (NICE) (2014). Psychosis and schizophrenia in adults: Prevention and management. Available at: https:\/\/www.nice.org.uk\/guidance\/cg178 (accessed 25 December 2022)."},{"key":"bibr26-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2014.08.017"},{"key":"bibr27-02698811231181565","unstructured":"Obesity Expert Panel (2013) Managing overweight and obesity in adults. Systematic review from the obesity expert panel. https:\/\/www.nhlbi.nih.gov\/health-topics\/managing-overweight-obesity-in-adults (accessed 9 June 2023)."},{"key":"bibr28-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003098"},{"key":"bibr29-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02536.x"},{"key":"bibr30-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30416-X"},{"key":"bibr31-02698811231181565","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00741"},{"key":"bibr32-02698811231181565","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.220"},{"key":"bibr33-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sby095"},{"key":"bibr34-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.06.002"},{"key":"bibr35-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbm141"},{"key":"bibr36-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2013.11.017"},{"key":"bibr37-02698811231181565","first-page":"22","volume":"59","author":"Sheehan DV","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"bibr38-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.03.112"},{"key":"bibr39-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009555.pub2."},{"key":"bibr40-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2013.07.003"},{"key":"bibr41-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2009.03.005"},{"key":"bibr42-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000347"},{"key":"bibr43-02698811231181565","first-page":"157","volume":"55","author":"Umbricht DS","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"bibr44-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.07020233"},{"key":"bibr45-02698811231181565","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61611-6"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811231181565","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811231181565","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811231181565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:11:25Z","timestamp":1777507885000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811231181565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1177\/02698811231181565"],"URL":"https:\/\/doi.org\/10.1177\/02698811231181565","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]}}}